ATE296098T1 - Verwendung von topiramat zur behandlung und diagnostizierung von atemstörungen während des schlafens und mittel zur durchführung der behandlung und diagnose - Google Patents
Verwendung von topiramat zur behandlung und diagnostizierung von atemstörungen während des schlafens und mittel zur durchführung der behandlung und diagnoseInfo
- Publication number
- ATE296098T1 ATE296098T1 AT01904764T AT01904764T ATE296098T1 AT E296098 T1 ATE296098 T1 AT E296098T1 AT 01904764 T AT01904764 T AT 01904764T AT 01904764 T AT01904764 T AT 01904764T AT E296098 T1 ATE296098 T1 AT E296098T1
- Authority
- AT
- Austria
- Prior art keywords
- diagnosis
- treatment
- topiramate
- sleep
- carrying
- Prior art date
Links
- KJADKKWYZYXHBB-XBWDGYHZSA-N Topiramic acid Chemical compound C1O[C@@]2(COS(N)(=O)=O)OC(C)(C)O[C@H]2[C@@H]2OC(C)(C)O[C@@H]21 KJADKKWYZYXHBB-XBWDGYHZSA-N 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title abstract 3
- 230000029058 respiratory gaseous exchange Effects 0.000 title abstract 3
- 229960004394 topiramate Drugs 0.000 title abstract 3
- 206010041235 Snoring Diseases 0.000 abstract 2
- 201000002859 sleep apnea Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Radiation-Therapy Devices (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Endoscopes (AREA)
- Medicinal Preparation (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0000601A SE0000601D0 (sv) | 2000-02-24 | 2000-02-24 | Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet |
| PCT/SE2001/000315 WO2001062243A1 (en) | 2000-02-24 | 2001-02-14 | Method of treating and diagnosing sleep disordered breathing and means for carrying out the method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE296098T1 true ATE296098T1 (de) | 2005-06-15 |
Family
ID=20278571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01904764T ATE296098T1 (de) | 2000-02-24 | 2001-02-14 | Verwendung von topiramat zur behandlung und diagnostizierung von atemstörungen während des schlafens und mittel zur durchführung der behandlung und diagnose |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7981443B2 (de) |
| EP (1) | EP1261333B1 (de) |
| JP (1) | JP4896334B2 (de) |
| AT (1) | ATE296098T1 (de) |
| AU (2) | AU3258801A (de) |
| CA (1) | CA2401000C (de) |
| DE (1) | DE60111025T2 (de) |
| DK (1) | DK1261333T3 (de) |
| ES (1) | ES2243444T3 (de) |
| NZ (1) | NZ520781A (de) |
| PT (1) | PT1261333E (de) |
| SE (1) | SE0000601D0 (de) |
| WO (1) | WO2001062243A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003026676A1 (en) * | 2001-09-24 | 2003-04-03 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder |
| SE0400378D0 (sv) * | 2004-02-17 | 2004-02-17 | Jan Hedner | Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet |
| CA2622721A1 (en) * | 2005-09-16 | 2007-03-22 | Cereuscience Ab | Method and means of preventing and treating sleep disordered breathing |
| US7725195B2 (en) | 2006-02-16 | 2010-05-25 | Imthera Medical, Inc. | RFID-based apparatus, system, and method for therapeutic treatment of obstructive sleep apnea |
| BRPI0716375A2 (pt) * | 2006-08-31 | 2013-10-15 | Univ Alberta | Método para reduzir ou inibir depressão respiratória em um sujeito; método para induzir analgesia, anestesia ou sedação em um sujeito, reduzindo ou inibindo simultaneamente depressão respiratória no sujeito; e composição farmacêutica para induzir analgesia, anestesia ou sedação em um sujeito... |
| US9744137B2 (en) * | 2006-08-31 | 2017-08-29 | Supernus Pharmaceuticals, Inc. | Topiramate compositions and methods of enhancing its bioavailability |
| EP2394643B1 (de) | 2006-11-17 | 2015-09-02 | Supernus Pharmaceuticals, Inc. | Topiramat-Formulierungen mit verzögerter Freisetzung |
| CN102114002B (zh) * | 2006-12-04 | 2016-05-11 | 苏佩努斯制药公司 | 托吡酯的增强的立即释放制剂 |
| US8071557B2 (en) * | 2007-06-13 | 2011-12-06 | Vivus, Inc. | Treatment of pulmonary hypertension with carbonic anhydrase inhibitors |
| EP2197535A4 (de) | 2007-10-09 | 2013-08-21 | Imthera Medical Inc | Vorrichtung, system und verfahren für selektive stimulationen |
| BRPI0920548B8 (pt) | 2008-10-09 | 2021-06-22 | Imthera Medical Inc | aparelho para controlar posição da língua de um paciente |
| JP2013509943A (ja) | 2009-11-10 | 2013-03-21 | イムセラ・メディカル・インコーポレーテッド | 舌下神経を刺激して患者の舌の位置を調節するシステム |
| US20110224196A1 (en) * | 2010-01-07 | 2011-09-15 | Vivus, Inc. | Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| CA2958110A1 (en) * | 2014-08-14 | 2016-02-18 | Vivus, Inc. | Treatment of sleep apnea with a combination of a carbonic anhydrase inhibitor and an aldosterone antagonist |
| DK3423062T3 (da) | 2016-05-11 | 2020-08-31 | Jan Hedner | Sultiam til behandlingen af søvnapnø |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| US7056890B2 (en) * | 1999-06-14 | 2006-06-06 | Vivus, Inc. | Combination therapy for effecting weight loss and treating obesity |
-
2000
- 2000-02-24 SE SE0000601A patent/SE0000601D0/xx unknown
-
2001
- 2001-02-14 EP EP01904764A patent/EP1261333B1/de not_active Expired - Lifetime
- 2001-02-14 WO PCT/SE2001/000315 patent/WO2001062243A1/en not_active Ceased
- 2001-02-14 AU AU3258801A patent/AU3258801A/xx active Pending
- 2001-02-14 PT PT01904764T patent/PT1261333E/pt unknown
- 2001-02-14 JP JP2001561310A patent/JP4896334B2/ja not_active Expired - Fee Related
- 2001-02-14 AT AT01904764T patent/ATE296098T1/de active
- 2001-02-14 ES ES01904764T patent/ES2243444T3/es not_active Expired - Lifetime
- 2001-02-14 DE DE60111025T patent/DE60111025T2/de not_active Expired - Lifetime
- 2001-02-14 AU AU2001232588A patent/AU2001232588B2/en not_active Ceased
- 2001-02-14 CA CA2401000A patent/CA2401000C/en not_active Expired - Fee Related
- 2001-02-14 NZ NZ520781A patent/NZ520781A/en not_active IP Right Cessation
- 2001-02-14 DK DK01904764T patent/DK1261333T3/da active
- 2001-02-14 US US10/204,048 patent/US7981443B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| SE0000601D0 (sv) | 2000-02-24 |
| DE60111025D1 (de) | 2005-06-30 |
| JP4896334B2 (ja) | 2012-03-14 |
| NZ520781A (en) | 2004-04-30 |
| ES2243444T3 (es) | 2005-12-01 |
| PT1261333E (pt) | 2005-09-30 |
| CA2401000C (en) | 2010-03-23 |
| US20040082519A1 (en) | 2004-04-29 |
| JP2003523384A (ja) | 2003-08-05 |
| AU2001232588B2 (en) | 2004-04-22 |
| CA2401000A1 (en) | 2001-08-30 |
| EP1261333A1 (de) | 2002-12-04 |
| EP1261333B1 (de) | 2005-05-25 |
| DK1261333T3 (da) | 2005-08-29 |
| AU3258801A (en) | 2001-09-03 |
| DE60111025T2 (de) | 2006-05-04 |
| WO2001062243A1 (en) | 2001-08-30 |
| US7981443B2 (en) | 2011-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60111025D1 (de) | Verwendung von Topiramat zur Behandlung und Diagnostizierung von Atemstörungen während des Schlafens und Mittel zur Durchführung der Behandlung und Diagnose | |
| DE69616376D1 (de) | Verwendung von Tiagabin zur Behandlung von Schlafstörungen | |
| ATE144420T1 (de) | Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen | |
| ATE348808T1 (de) | Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten | |
| DE60227658D1 (de) | Verfahren zur behandlung neurodegenerativer, psychiatrischer und anderer störungen mit deacetylaseinhibitoren | |
| ATE207351T1 (de) | Verwendung vonmodafinil zur behandlung von atemstillstand im schlaf und zentral erregten atembeschwerden | |
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| DE69923998D1 (de) | Verwendung eines neurologischen wirkstoffes zur herstellung eines medikamentes zur behandlung von erkrankungen des zentralen nervensystems | |
| DE602004017888D1 (de) | Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure | |
| DE69333014D1 (de) | Verwendung von 4-aminopyridin zur behandlung von schmerz und spastik folgende einer verletzung des rückenmarks | |
| ATE410163T1 (de) | Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens | |
| DE59914712D1 (de) | Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden | |
| NO982989L (no) | Anvendelse av inhibitorer av den cellulµre Na+/H+-utbytteren (NHE) for fremstilling av et medikament for respiratorstimulering | |
| NO20064964L (no) | Behandling av svekket respiratorisk funksjon | |
| DE69516110D1 (de) | Verwendung von riluzol zur behandlung mitochondrialer erkrankungen | |
| DE69928521D1 (de) | Cabergolin und pramipexol zur behandlung von krankheiten des zentralnervensystems, insbesondere parkinsonscher krankheit | |
| BR9908190A (pt) | Processos para tratar a dor especìfica de fêmea em um paciente fêmea, e para tratar a dor crÈnica em um paciente | |
| MX2023003258A (es) | Tratamiento de enfermedades mediadas por nf-kb. | |
| BR0311180A (pt) | Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos | |
| EA200600989A1 (ru) | Применение габоксадола для лечения бессонницы | |
| DE69630055D1 (de) | Verwendung von olanzapin oder eines salzes für die herstellung eines medikaments für die behandlung von autismus und mentaler retardation | |
| ATE236630T1 (de) | Verwendung von sklareolide für die behandlung von excessiven zellwachstumskrankheiten | |
| DE60024408D1 (de) | Verwendung von trizyklischen antidepressiva zur behandlung von kopfschmerzen | |
| SU950354A1 (ru) | Способ лечени синдрома зап стного канала | |
| ATE382367T1 (de) | Behandlung des typ 1 diabetes vor und nach expression von prädispositionsmarkern |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1261333 Country of ref document: EP |